Health: Going beyond lifestyle factors

Wealth and inequality impact blood pressure in a population with the lowest risk of heart disease in the world.
  1. Milagros Ruiz  Is a corresponding author
  1. Research Department of Epidemiology and Public Health, University College London, United Kingdom

The idea of a ‘social ladder’ may be metaphorical, but actual and perceived societal ranking have real consequences for the health of an individual (Adler et al., 2000). How social structure influences health and disease is overwhelmingly studied in high-income countries, where coronary heart disease (CHD for short) is the leading cause of death (Institute for Health Metrics and Evaluation, 2019).

In these societies, the relationship between an individual’s social position and their CHD risk is astonishingly consistent, with disadvantaged populations being more likely to suffer from the disease and to die from it (Schultz et al., 2018). Despite the clarity of this evidence, the public health workforce has not yet reached a unified consensus on why these inequalities occur, and what can be done to reduce them (Marmot, 2004).

Lifestyle factors such as diet, sedentarism or smoking, and their ensuing effects like hypertension, only partially account for the excess burden of CHD in disadvantaged groups (Schultz et al., 2018). Yet primary prevention efforts appear to focus on these health behaviours over other factors linked to social inequality. In fact, targeting lifestyle alone is likely to exacerbate inequalities in post-industrial societies (Marmot, 2004).

Investigating inequalities in populations that have not adopted Western diets and activity levels – a challenging undertaking given the proliferation of this lifestyle worldwide – could be a way to confront the underlying assumption that behavioural differences are responsible for the observed inequality in CHD (Kopp, 2019). Now, in eLife, Adrian Jaeggi (University of Zurich and Emory University), Aaron Blackwell (Washington State University) and co-workers based in the United States, France and Germany report the most comprehensive study on social structure and health in a pre-industrial society in the Bolivian Amazon known as the Tsimane (Jaeggi et al., 2021). 

This population relies on subsistence farming supplemented by hunter-gatherer practices, resulting in an extremely physically active life and a diet that is rich in fibres and micronutrients. In turn, they have remarkably modest rates of obesity and hypertension, and the lowest prevalence of biological markers for poor artery health ever recorded around the world (Pontzer et al., 2018). Thus, any putative relationship between social position and heart health is unlikely to be the result of differences in health behaviour.

Overall, Jaeggi et al. discovered consistent links between wealth-related circumstances and blood pressure in the Tsimane: the poorer the individual, the higher their blood pressure. In people over the age of 15, the pressure on artery walls during and between heartbeats was lower in those with higher household wealth, that is, those with more common household assets: this can include traditional goods made from local organic materials, industrially produced items acquired through trade or purchase, and livestock. The researchers also investigated the association between wealth inequality and overall health in several geographically separated communities – defined as clusters of households connected through kin networks that produce or consume food together. They found that communities with greater inequality between rich and poor members had higher blood pressure.

Most Tsimane have normal blood pressure. This means that associations between wealth and individual blood pressure within communities, or between wealth inequality and overall blood pressure across communities both capture variations below a clinically significant level (Jaeggi et al., 2021; Pontzer et al., 2018). However, these findings are not inconsequential: in post-industrial societies, small reductions in blood pressure in the overall population have proved effective in lowering CHD incidence (Cook et al., 1995).

If no members of the Tsimane population live an unhealthy lifestyle, and if they all have little to no access to healthcare, then what drives higher blood pressure in poorer adults and in more unequal communities? Psychosocial mechanisms and pathways to poor health may provide an answer, drawing on how feelings which result from inequality, domination, or subordination may directly alter biological processes (Bartley, 2017). Social hierarchies, maintained by societal arrangements of power, lead to disadvantaged populations being disproportionally exposed to psychosocial stressors such as lack of community support, low control and autonomy, and an imbalance between effort and reward. In turn, psychosocial stress can have a severe impact on the body, triggering a sustained fight or flight response and altering the hormone system that controls biological reactions to stress (Bartley, 2017; Jaeggi et al., 2021).

Jaeggi et al. therefore tested how psychosocial factors related to unequal wealth and wealth distribution may have influenced feelings and interactions among the Tsimane (e.g., depression, social conflicts), or altered their body chemistry (e.g., the level of the stress hormone cortisol in urine). The analyses highlighted a weak connection between these factors and increased levels of blood pressure in individuals who possess less wealth or are from more unequal communities. However, this link may only be weakly supported by the analyses because the markers used could have insufficiently measured psychosocial stress. It may therefore be worth also examining whether a pathway can be identified when looking at C-reactive protein, an inflammatory biomarker for blood pressure which is relatively elevated in the Tsimane population (Pontzer et al., 2018). Yet, detecting these small effects in such a healthy society requires a large sample size, and psychosocial markers were only collected in a subset of participants with blood pressure data: thus, it is more likely that the analyses were underpowered.

The Tsimane face growing exposure to psychosocial stress as contact with ethnic majority groups increase, and their economy becomes more integrated. These developments urge researchers to explore individual-level and macro-level mechanisms for health inequality in the Tsimane, and remind us, once again, to look beyond lifestyle when tackling public health problems.

References

  1. Book
    1. Bartley M
    (2017)
    Health Inequality: An Introduction to Concepts, Theories and Methods
    Cambridge Polity Press.

Article and author information

Author details

  1. Milagros Ruiz

    Milagros Ruiz is in the Research Department of Epidemiology and Public Health, University College London, London, United Kingdom

    For correspondence
    m.a.ruiz@ucl.ac.uk
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7492-9873

Publication history

  1. Version of Record published: June 24, 2021 (version 1)

Copyright

© 2021, Ruiz

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 884
    views
  • 55
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Milagros Ruiz
(2021)
Health: Going beyond lifestyle factors
eLife 10:e70548.
https://doi.org/10.7554/eLife.70548
  1. Further reading

Further reading

    1. Epidemiology and Global Health
    Zhanwei Du, Lin Wang ... Lauren A Meyers
    Short Report

    Paxlovid, a SARS-CoV-2 antiviral, not only prevents severe illness but also curtails viral shedding, lowering transmission risks from treated patients. By fitting a mathematical model of within-host Omicron viral dynamics to electronic health records data from 208 hospitalized patients in Hong Kong, we estimate that Paxlovid can inhibit over 90% of viral replication. However, its effectiveness critically depends on the timing of treatment. If treatment is initiated three days after symptoms first appear, we estimate a 17% chance of a post-treatment viral rebound and a 12% (95% CI: 0%-16%) reduction in overall infectiousness for non-rebound cases. Earlier treatment significantly elevates the risk of rebound without further reducing infectiousness, whereas starting beyond five days reduces its efficacy in curbing peak viral shedding. Among the 104 patients who received Paxlovid, 62% began treatment within an optimal three-to-five-day day window after symptoms appeared. Our findings indicate that broader global access to Paxlovid, coupled with appropriately timed treatment, can mitigate the severity and transmission of SARS-Cov-2.

    1. Epidemiology and Global Health
    Yuchen Zhang, Yitang Sun ... Kaixiong Ye
    Research Article

    Background:

    Circulating omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been associated with various chronic diseases and mortality, but results are conflicting. Few studies examined the role of omega-6/omega-3 ratio in mortality.

    Methods:

    We investigated plasma omega-3 and omega-6 PUFAs and their ratio in relation to all-cause and cause-specific mortality in a large prospective cohort, the UK Biobank. Of 85,425 participants who had complete information on circulating PUFAs, 6461 died during follow-up, including 2794 from cancer and 1668 from cardiovascular disease (CVD). Associations were estimated by multivariable Cox proportional hazards regression with adjustment for relevant risk factors.

    Results:

    Risk for all three mortality outcomes increased as the ratio of omega-6/omega-3 PUFAs increased (all Ptrend <0.05). Comparing the highest to the lowest quintiles, individuals had 26% (95% CI, 15–38%) higher total mortality, 14% (95% CI, 0–31%) higher cancer mortality, and 31% (95% CI, 10–55%) higher CVD mortality. Moreover, omega-3 and omega-6 PUFAs in plasma were all inversely associated with all-cause, cancer, and CVD mortality, with omega-3 showing stronger effects.

    Conclusions:

    Using a population-based cohort in UK Biobank, our study revealed a strong association between the ratio of circulating omega-6/omega-3 PUFAs and the risk of all-cause, cancer, and CVD mortality.

    Funding:

    Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.